Lipid metabolism, non-GMP-like AML blasts hierarchy, microenvironment-enriched M2 macrophages, and resistance to standard chemotherapy agents characterize the AML cells with high ME1 expression, possibly explaining their association with poor outcomes in AML-HSCT. Here, ME1 is linked to acute myeloid leukemia.